News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
297,068 Results
Type
Article (15773)
Company Profile (261)
Press Release (281027)
Multimedia
Podcasts (127)
Webinars (13)
Section
Business (90902)
Career Advice (170)
Deals (13538)
Drug Delivery (69)
Drug Development (51156)
Employer Resources (32)
FDA (6018)
Job Trends (5235)
News (146076)
Policy (10103)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (19)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Standard (3)
40 Under 40 (4)
Academia (981)
Accelerated approval (39)
ADA (35)
Adcomms (16)
Allergies (128)
Alliances (21782)
ALS (204)
Alzheimer's disease (1263)
Antibody-drug conjugate (ADC) (582)
Approvals (6455)
Artificial intelligence (491)
ASCO (225)
Autoimmune disease (410)
Automation (20)
Bankruptcy (112)
Belgium (29)
Best Places to Work (4568)
BIO (56)
Biologics (71)
BIOSECURE Act (6)
Biosimilars (161)
BioSpace Insights (81)
Biotechnology (179)
Bispecific (54)
Bladder cancer (143)
Brain cancer (73)
Breast cancer (511)
Cancer (5049)
Cardiovascular disease (377)
Career advice (174)
Career pathing (15)
CAR-T (347)
CDC (11)
CDMO (128)
Celiac Disease (6)
Cell therapy (891)
Cervical cancer (31)
Clinical research (46689)
Collaboration (1781)
Commercialization (44)
Company closure (4)
Compensation (987)
Complete response letters (73)
COVID-19 (1159)
CRISPR (131)
CRO (4)
C-suite (1059)
Cystic fibrosis (132)
Data (7644)
Denatured (27)
Depression (134)
Dermatology (131)
Diabetes (405)
Diagnostics (1563)
Digital health (21)
Diversity (6)
Diversity, equity & inclusion (9)
Drug discovery (360)
Drug pricing (55)
Drug shortages (4)
Duchenne muscular dystrophy (343)
Earnings (33962)
Editorial (37)
Employer branding (4)
Employer resources (30)
ESMO (312)
Events (55642)
Executive appointments (805)
Eye disease (16)
FDA (8843)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (6)
Friedreich's ataxia (28)
Frontotemporal dementia (36)
Funding (1495)
Gene editing (264)
Generative AI (50)
Gene therapy (726)
GLP-1 (638)
Government (1218)
Grass and pollen (3)
Guidances (182)
Healthcare (6836)
Hematology (144)
HIV (40)
Huntington's disease (75)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (125)
Immunology and inflammation (294)
Immuno-oncology (122)
Indications (193)
Infectious disease (1341)
Inflammatory bowel disease (216)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (262)
Interviews (21)
IPO (7433)
IRA (13)
Job creations (873)
Job search strategy (139)
JPM (41)
Kidney cancer (13)
Kidney disease (125)
Labor market (46)
Layoffs (280)
Leadership (22)
Legal (1407)
Licensing (99)
Liver cancer (54)
Longevity (39)
Lung cancer (700)
Lung diease (19)
Lymphoma (369)
Machine learning (37)
Management (8)
Manufacturing (718)
Marketing (25)
MASH (189)
Medical affairs (4)
Medical device (2766)
Medtech (2821)
Melanoma (111)
Mergers & acquisitions (6991)
Metabolic disorders (1118)
Middle East (1)
mRNA (231)
Multiple sclerosis (162)
Multispecific (6)
NASH (14)
Netherlands (19)
Neurodegenerative disease (433)
Neuropsychiatric disorders (105)
Neuroscience (2778)
Neurotech (2)
NextGen: Class of 2026 (2041)
Non-profit (893)
Now hiring (50)
Obesity (496)
Opinion (161)
Ovarian cancer (233)
Pain (174)
Pancreatic cancer (310)
Parkinson's disease (366)
Partnered (19)
Patents (512)
Patient advocacy (7)
Patient recruitment (682)
Patient selection (93)
Peanut (55)
People (28001)
Peptides (33)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (16527)
Phase 2 (21727)
Phase 3 (13750)
Pipeline (9247)
Policy (114)
Postmarket research (853)
Preclinical (6981)
Press Release (30)
Prostate cancer (247)
Psychedelics (89)
Radioligand (3)
Radiopharmaceuticals (342)
Rare diseases (1132)
Real estate (1462)
Recruiting (12)
Regenerative medicine (24)
Regulatory (11479)
Reports (33)
Research institute (1009)
Resumes & cover letters (20)
Rett syndrome (51)
RNA editing (38)
RSV (26)
Schizophrenia (175)
Series A (295)
Series B (198)
Series C (1)
Service/supplier (1)
Sickle cell disease (110)
Special edition (24)
Spinal muscular atrophy (131)
Sponsored (22)
Startups (2059)
State (1)
Stem cells (7)
Stomach cancer (7)
Substance use disorders (20)
Supply chain (49)
Switzerland (14)
Tariffs (20)
The Weekly (98)
Vaccines (478)
Venture capital (120)
Weight loss (263)
Wet AMD (6)
Women's health (63)
Women in leadership (1)
Worklife (4)
Date
Today (67)
Last 7 days (417)
Last 30 days (2263)
Last 365 days (18546)
2026 (16924)
2025 (18110)
2024 (20494)
2023 (22453)
2022 (26854)
2021 (27820)
2020 (23385)
2019 (16243)
2018 (11752)
2017 (13766)
2016 (11849)
2015 (14358)
2014 (10397)
2013 (7489)
2012 (7548)
2011 (7618)
2010 (7448)
Location
Africa (161)
Alabama (86)
Alaska (2)
Arizona (108)
Arkansas (6)
Asia (19327)
Australia (3328)
California (10484)
Canada (2600)
China (1381)
Colorado (397)
Connecticut (395)
Delaware (364)
Europe (41449)
Florida (1380)
Georgia (289)
Hawaii (3)
Idaho (18)
Illinois (656)
India (78)
Indiana (248)
Iowa (13)
Japan (408)
Kansas (93)
Kentucky (13)
Louisiana (18)
Maine (14)
Maryland (1071)
Massachusetts (8369)
Michigan (143)
Minnesota (364)
Mississippi (4)
Missouri (41)
Montana (17)
Nebraska (6)
Nevada (71)
New Hampshire (22)
New Jersey (2387)
New Mexico (14)
New York (2550)
North Carolina (1213)
North Dakota (9)
Northern California (5449)
Ohio (254)
Oklahoma (12)
Oregon (28)
Pennsylvania (1899)
Puerto Rico (12)
Rhode Island (31)
South America (217)
South Carolina (20)
Southern California (4258)
Tennessee (72)
Texas (1513)
United States (34590)
Utah (145)
Virginia (212)
Washington D.C. (37)
Washington State (850)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
297,068 Results for "mati therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Mati Therapeutics Announces Promotion of Chris Muller to Chief Operating Officer
Mati Therapeutics Inc. announced that it has promoted Chris Muller to the position of Chief Operating Officer.
September 26, 2023
·
3 min read
Lone Star Bio
Mati Therapeutics Announces Completion of Manufacturing Facility Dedicated to Global Production of All Punctal Plug Delivery System (PPDS) Products
Mati Therapeutics Inc. announced that it has completed and now occupies a facility dedicated to manufacturing all products formulated in Mati’s proprietary Evolute® sustained ocular drug delivery platform.
September 12, 2023
·
2 min read
Funding
Marrow Therapeutics debuts with $173M to tackle blood disorders in vivo
Marrow Therapeutics aims to address safety and accessibility obstacles in genetic medicines by delivering therapies straight to bone marrow cells.
November 17, 2026
·
2 min read
·
Gabrielle Masson
Lone Star Bio
Mati Therapeutics Announces Purchase of Rights From Novelion Therapeutics Inc.
Mati Therapeutics Inc. (“Mati”) announced that it has purchased all rights related to Mati’s Evolute Punctal Plug Delivery System (PPDS) from Novelion Therapeutics Inc. (“Novelion”). This purchase is part of Novelion’s voluntary liquidation process
February 1, 2021
·
2 min read
Press Releases
Akebia Therapeutic’s Vafseo® (vadadustat) Granted Additional Patent
November 17, 2026
·
10 min read
Policy
Ocular Therapeutix™ Announces Success in Patent Appeal Brought by Mati Therapeutics, Inc.
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., invalidated a patent held by Mati Therapeutics, Inc. (Mati) relating to a drug delivery system containing dexamethasone.
November 9, 2021
·
7 min read
Press Releases
Seawolf Therapeutics Debuts With $100 Million to Advance DNA-Based Therapeutics
November 16, 2026
·
3 min read
Press Releases
Anacalypsis Therapeutics Raises Pre-Seed Financing Led by Metavallon VC to Advance a First-in-Class Therapeutic Strategy for Parkinson’s Disease
Athens-based biotech will use the financing to advance AT001, its lead therapeutic program targeting the LRRK2–FADD interaction, through a key in vivo efficacy study.
September 21, 2026
·
1 min read
Press Releases
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
October 13, 2026
·
11 min read
Press Releases
Odyssey Therapeutics Announces Publication Highlighting Differentiated Therapeutic Potential of TNFR2 Agonism
November 10, 2026
·
5 min read
1 of 29,707
Next